This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors | MicrobiomeTrials
← Back to trials NCT06041516
A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-06-17Est. Completion: 2027-10-30
Enrollment target: 70 participantsLocations National Institutes of Health Clinical Center, Bethesda, Maryland, United States Other microbiome trials you might be interested in Extensive-Stage Small Cell Lung Cancer Extrapulmonary Neuroendocrine Carcinoma Recurrent or Refractory Solid Tumors
Background:
Small cell lung cancer (SCLC) is the deadliest form of lung cancer. Extrapulmonary neuroendocrine cancer (E…
Bethesda, United States Est. completion Jan 30, 2030
Melanoma Li-Fraumeni Syndrome Pulmonary Blastoma Chordoma Congenital Bone Marrow Failure Syndromes Costello Syndrome
Fanconi Anemia
CFC Syndrome (CFCS)
Legius Syndrome
RASopathies
Background:
Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer…
Rockville, United States Est. completion Jan 1, 2035
Clinical Stage III Cutaneous Melanoma AJCC v8 Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 Clinical Stage IV Cutaneous Melanoma AJCC v8 Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 Metastatic Basal Cell Carcinoma Metastatic Carcinoma in the Skin Metastatic Melanoma Metastatic Merkel Cell Carcinoma Metastatic Skin Squamous Cell Carcinoma Unresectable Basal Cell Carcinoma Unresectable Melanoma Unresectable Merkel Cell Carcinoma Unresectable Skin Squamous Cell Carcinoma
This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of…
La Jolla, United States Est. completion Jan 31, 2027